by Clinical Neuropsychologist Online | Thursday, February 13, 2025 | Neuropsychology (general)
Neuropsychology, Vol 39(2), Feb 2025, 187-199; doi:10.1037/neu0000991Objective: Neurocognitive performance in attention-deficit/hyperactivity disorder (ADHD) is heterogeneous; some individuals with ADHD demonstrate neurocognitive deficits while others display none....
by Clinical Neuropsychologist Online | Wednesday, February 12, 2025 | Neuroimaging
ABSTRACT Background and Purpose Structural MRI (sMRI) is used in monitoring multiple sclerosis (MS) but lacks sensitivity in detecting clinically relevant damage to normal-appearing white matter (NAWM), that is, pre-lesional tissue, and specificity for identifying the...
by Clinical Neuropsychologist Online | Wednesday, February 12, 2025 | Dementia
Abstract BACKGROUND Despite significant astrocytic involvement in Parkinson’s disease (PD), the knowledge regarding the role of reactive astrogliosis is still at the surface level; largely due to lack of specific biomarkers to track these processes. Novel...
by Clinical Neuropsychologist Online | Wednesday, February 12, 2025 | Dementia
Abstract INTRODUCTION One of the pathological hallmarks of Alzheimer’s disease (AD) is the accumulation of amyloid beta 42 (Aβ42). Decreased venous drainage may enhance Aβ42 accumulation. We aimed to compare venous cross-sectional area (CSA) of AD patients to...
by Clinical Neuropsychologist Online | Wednesday, February 12, 2025 | Dementia
Abstract INTRODUCTION There is an unmet need for tools to quantify dementia risk during its multi-decade preclinical/prodromal phase, given that current biomarkers predict risk over shorter follow-up periods and are specific to Alzheimer’s disease. METHODS Using...
